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Comparative outcomes of primary autogenous
fistulas in elderly, multiethnic Asian hemodialysis
patients
Claude J. Renaud, MRCP (UK), FAMS,a Jackie Ho Pei, FRCS,b Evan J. C. Lee, FRCP, MD,a
Peter A. Robless, FRCS,b and Anantharaman Vathsala, FRCP, MD,a Singapore
Background: The number of elderly (>65 years) end-stage renal disease (ESRD) patients on hemodialysis is rapidly
increasing. Vascular access outcomes remain contradictory and understudied across different elderly populations. We
hypothesized age might influence primary autogenous fistula use and outcomes in a predominantly diabetic multiethnic
Asian ESRD population.
Methods:Demographic and clinical factors affecting fistula patency and maturation were retrospectively compared among
patients with incident ESRD aged <65 and >65 years at a single center. Fistula patency was estimated by Kaplan-Meier
curves with log-rank test comparison.
Results:We analyzed 280 primary fistulas (59% radiocephalic, 33% brachiocephalic, and 8% brachiobasilic) in this cohort
consisting of 31.8% aged >65 years, 50% Chinese, 39% Malay, 42% women, and 70% diabetic. One- and 2-year primary
and secondary patency in patients aged <65 vs >65 years were comparable: 41.3% vs 36.7% and 28.7% vs 24.4% (P 
.547) and 57.7% vs 56.8% and 47.1% vs 47.2% (P .990). On multivariate analysis, only non-Chinese, dialysis initiation
with tunneled catheters, and surgical/endovascular interventions affected fistula survival hazard ratios (HR): 0.622 (95%
confidence interval [CI], 0.43-1.00), 0.549 (95% CI, 0.297-0.841), and 2.503 (95% CI, 1.695-3.697), respectively.
Nonmaturation and intervention rates were also similar at 56.7% vs 61.8% and 34% vs 32.2% at 3 and 6 months and 0.31
vs 0.36 per access year, respectively (P > .05). Females and tunneled catheters were the only risk factors for
nonmaturation (HR, 1.568; 95% CI, 1.148-1.608, and HR, 1.623; 95% CI, 1.400-1.881, respectively).
Conclusions: A primary fistula strategy in incident elderly ESRD is feasible and does not result in inferior outcomes. Age
should therefore not be a determinant for primary fistula creation. (J Vasc Surg 2012;56:433-9.)
t
t
u
a
s
d
t

u
l
w
s
M
t
E
2
S
y
p
t
a
aThe elderly (aged65 years) account for an increasing
number of end-stage renal disease (ESRD) patients initiat-
ing hemodialysis. In Europe, they represent 39% to 70% of
patients,1,2 whereas in the United States, the figure is
50%.3 Two of Asia’s largest hemodialysis populations also
show a similar demographic trend: mean age is 67.2 years in
Japan,4 and 40% of Taiwanese ESRD incident patients are
elderly.5 In smaller but more multiethnic Singapore, the
mean and median age of incident patients is 60 years and
rising.6
The age epidemic has been paralleled by a high inci-
dence of diabetic ESRD, coronary artery disease (CAD),
and peripheral artery disease (PAD).3,7 The elderly are also
twice as likely to die within the first year of hemodialysis
compared to the nonelderly.8 It has hence been argued that
prosthetic grafts and tunneled catheters (TCs) should be
the primary vascular access of choice in this age group given
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doi:10.1016/j.jvs.2012.01.063he perceived lack of potential benefits of autogenous (ar-
eriovenous) fistulas (AVFs).2,9-11
Vascular access clinical practice guidelines advocate
niversal primary distal AVFs but disregard the challenges
nd lack of consensus for AVFs in the elderly.12,13 Retro-
pective studies have also produced contradictory results in
ifferent populations.5,9,14,15
The purpose of this single-center study therefore was
o compare primary AVF outcomes among patients aged
65 and 65 years in an aging multiethnic Asian pop-
lation known to have a high diabetic ESRD preva-
ence.6 We hypothesized that patients aged 65 years
ould have higher AVF nonmaturation, failure, and
alvaging interventions.
ETHODS
Patients. This was a retrospective study of prospec-
ively collected data on a cohort of consecutive incident
SRD patients initiating hemodialysis from January 1,
008 through December 31, 2010 at a tertiary hospital in
ingapore, and who received dialysis at satellite hemodial-
sis centers through October 31, 2011. We reviewed all
rimary AVFs created for dialysis during that period. Insti-
utional review board approval was obtained for this study.
Inclusion and exclusion criteria. We excluded from
nalysis primary prosthetic grafts, patients aged 21 years,
nd those dialyzed exclusively by TCs or followed up at
ther institutions. Selected patients were divided into two
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August 2012434 Renaud et algroups based on age at AVF creation: group A was aged
65 years and group B65 years. Upper limb vein disten-
sibility and arterial pulse but not digital pressure was as-
sessed preoperatively. Duplex ultrasound venous mapping
(VM) and arterial waveforms assessment were routinely
performed by experienced vascular ultrasound technicians.
Venographic VMwas not performed to examine the central
veins in patients with a history of TC use. Suboptimal
vessels were classified as any vein with a diameter2.5 mm
with or without thrombus or stenosis in the outflow
and/or an artery2 mm with biphasic flow. However, the
final decision for AVF selection was based on the individual
surgeons’ discretion and in keeping with clinical guidelines
that stipulate a distal AVF-first approach.12,13 Primary bra-
chiobasilic transposed (BBT) AVFs (BBTAVFs) were
mostly created in a two-stage procedure.
Fistulas were reviewed routinely at 7 days and at 8 to 12
weeks postoperatively and cannulated with two needles at 8
to 12 weeks if deemed clinically mature. AVFs that were
difficult to cannulate were reassessed physically and by
ultrasound imaging, and those with inflow or outflow
stenoses, accessory veins, and 5 mm deep were revised
endovascularly or surgically. Also assessed were patients
referred for arm edema, hand ischemia, prolonged cannu-
lation site bleeding after dialysis, low blood flow (200
mL/min), high venous pressure (150 mm Hg), access
flow 400 mL/min, or recirculation 5% based on rou-
tine Transonic monitoring (Transonic Systems Inc, Itheca,
NY) available in 60% of dialysis centers.
Data collection. Baseline demographic information
and patient and AVF characteristics were retrieved from
clinical notes and the hospital electronic database. Each
Fig 1. Cohort selection flow diagram shows patients w
hemodialysis (HD) with autogenous arteriovenous fistulAVF was assigned a nonmaturation risk score of3 or3, Phich denotes a 35% and 50% risk of nonmaturation,
espectively, based on a validated scoring system.16
Study end points and definitions. Primary outcome
easures were primary AVF patency (PP) and secondary
atency (SP) as defined by Sidawy et al.17 Patients were
ensored at the time of death, irreversible thrombosis, AVF
igation, transplantation, or peritoneal dialysis conversion.
econdary end points were nonmaturation, rate of surgical
nd endovascular interventions, and postpercutaneous
ransluminal angioplasty (PTA) SP, the latter according to
ociety of Interventional Radiology guidelines.18
Nonmaturation was defined as any created AVF that
ailed to develop well enough to be cannulated with two
eedles and provide prescribed dialysis for at least six con-
ecutive sessions or TC removal by 3 months postopera-
ively, or both. Catheter removal was used preferentially
ecause often a significant delay occurred between the first
eedling and reliable use of the AVF. Fistulas created
redialysis were considered mature if they were needled
uccessfully at the time of dialysis initiation. Fistula-salvaging
nterventions consisted of PTA or stenting, or both,
hrombolysis/thrombectomy, fistula superficialization,
nastomotic revision, aneurysmal repair, revascularization
rocedures for steal syndrome, and ligation of competing
ccessory veins but not AVF ligation or purely diagnostic
ngiograms. A timely referral was defined as any first ne-
hrology visit 6 months before hemodialysis initiation.
Statistical analysis. Categoric data are expressed as
ercentages and continuous data as means  standard
eviation or range and were compared using 2 analysis and
he Student t-test or Mann-Whitney test, respectively. Ka-
lan-Meier analysis and log-rank test were used to estimate
nd-stage renal disease (ESRD) undergoing long-term
F) or HD only with a tunneled catheter (TC).ith eP and SP. Cox regression analysis was used to determine
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Volume 56, Number 2 Renaud et al 435factors independently associated with AVF SP. Selected vari-
ables have been shown to influence vascular access outcomes
in previous publications.9,11,14-16 The level of significancewas
two-sided and set as P  .05. All analyses were conducted
using SPSS 20 software (SPSS Inc, Chicago, Ill).
RESULTS
The study included 280 of 363 hemodialysis ESRD
patients (Fig 1): 68.2% in group A (aged 65 years) and
31.8% in group B (aged 65 years). Patient characteristics
are summarized in Table I.
PP and SP rates at 6, 12, and 24 months were compa-
rable (Tables II and III, Fig 2). Patency rates based on AVF
type also yielded similar results (Tables II and III). Inflow
stenosis was the most common angiographic cause of PP
loss (73.2% vs 56.7%), followed by outflow stenosis (25% vs
36.7%) and combined lesions (1.8% vs 6.7%) out of 56 and
30 angiographies in groups A and B, respectively (P 
.202). AVF abandonment in group A was due to 77 throm-
boses (40.3%), comprising two perioperative, 1030 days
postoperative, and 65 30 days postoperative; four liga-
Table I. Baseline demographic and vascular access
characteristics
Baseline characteristica
65 years
(n  191)
65 years
(n  89) P
Age, years 52  9 72  5.00
AVF follow-up, months 12 (0-89) 13 (0-43) .84
Race
Chinese 93 (48.7) 48 (53.9) .80
Malay 78 (40.8) 31 (34.8)
Female sex 77 (40.3) 40 (44.9) .52
Diabetes mellitus 133 (69.6) 63 (70.8) .89
Coronary artery disease 79 (41.4) 44 (49.4) .21
Peripheral artery disease 34 (17.8) 20 (22.5) .42
Antiplatelet medicationsb 84 (44) 48 (53.9) .13
Clopidogrel 13 (6.8) 16 (18) .09
Warfarin 4 (2.1) 1 (1.1) .01
Late referral (6 months) 55 (28.8) 20 (22.5) .31
Maturation scorec
3 95 (49.7) 0 .02
3 96 (50.3) 89 (100)
Ultrasound vein mapping 164 (85.9) 75 (84.3) .75
Suboptimal vessels 102 (53.4) 50 (56.2)
AVF type
Radiocephalic 112 (58.6) 54 (60.7)
Brachiocephalic 66 (34.6) 27 (30.3) .69
Brachiobasilic 13 (6.8) 8 (9.0)
Access at HD initiation
Mature pre-HD AVF 30 (15.8) 17 (19.1)
Nonmatured AVFd 13 (6.8) 8 (10) .61
Tunneled catheter 147 (77.4) 64 (71.9)
AVF, Autogenous arteriovenous fistula; HD, hemodialysis.
aContinuous data are shown as mean  standard deviation or median
(range) and categoric data as number (%).
bFour patients in the 65 group and one in the 65 group were taking
warfarin and are not included.
cPredictive maturation score based on Lok et al.16
dNonmature or thrombosed pre-HD AVF and dialysis initiated with a
tunneled catheter.tions (2.1%); five transplants (2.6%); and 13 deaths (6.8%). dt the end of follow-up, 92 AVFs (48.2%) remained func-
ional. In group B, AVFs were abandoned as the result of
5 thromboses (39.3%), comprising three perioperative,
wo 30 days postoperative, and 30 30 days postopera-
ive; two AVF ligations (2.2%); and 10 deaths (11.2%). At
he end of follow-up, 42 (47.2%) AVFs remained patent.
ox regression multivariate analysis showed only dialysis
nitiation with a TC, Chinese ethnicity, and AVF-salvaging
nterventions were significantly associated with AVF sur-
ival (Table IV).
Nonmaturation was 57.6% in group A and 61.8% in
roup B (P .518). Female sex and dialysis initiation with
TC were significant risk factors (Table V). Group B had a
igher baseline predictive nonmaturation risk score (Table
), but neither age nor a risk score3 were associated with
onmaturation. A higher but nonsignificant number of
BTAVFs failed to mature by 3 months than radiocephalic
RC) and brachiocephalic (BC) AVFs, largely as a result of
mean waiting time of 2.5 months for the second-stage
rocedure (76% vs 57% vs 58%, respectively; P .79). Two
BTAVFs were created by a one-stage procedure and six
ere lost before superficialization could be done. Using a
-month maturation cutoff gave lower but still comparable
onmaturation rates of 34% in group A vs 32.6% in group B
P  .811) and 33.1% in RCAVFs, 30.1% in BCAVFs, and
2.4% in BBTAVFs (P .161). However, the effect of sex
ecame nonsignificant at 6 months.
A total of 126 procedures were performed: 83 in group
and 43 in group B. Interventions per access year were
.40 overall and 0.34 vs 0.36 in groups A and B, respec-
ively (P .512). The interventions performed are summa-
ized in Table VI. Excluded were eight AVF ligations (six in
roup A and two in group B) and three diagnostic angio-
rams without PTA. Angioplasty technical failure (ie, resid-
al stenosis 30% or failure to cross stenoses) was signifi-
antly higher in group B, at 20% (seven of 35) vs 0% (P 
00). SP at 1 and 2 years after PTA was similar: 77.4% vs
1.3% and 65.5% vs 51.5% in groups A and B, respectively
log-rank, P  .81). Three transbrachial artery PTAs in
roup A resulted in arterial pseudoaneurysm and all three
ere surgically repaired. Venous rupture occurred after
utflow stenosis PTA in two patients in group A, with one
atient (a BBTAVF) requiring stenting. Steal syndrome
ccurred in one RCAVF and two BCAVFs in group A and
ne RCAVF and one BBTAVF in group B. In all cases, the
VF was ligated after Doppler ultrasound imaging con-
rmed reduced antegrade flow in markedly diseased radial
nd ulnar arteries rendering them unamenable to revascu-
arization or arterial PTA except for one BCAVF in group
, which underwent distal revascularization interval liga-
ion. Four AVF infections occurred in group A and none in
roup B. Two BBTAVFs were treated conservatively, and
wo BCAVF abscesses were drained and ligated. No deaths
ere directly related to AVF creation or its complications.
eaths in groups A and B were comparable and due to
nfections (three vs four), malignancy (two vs one), cardio-
ascular complications (seven vs four), and dialysis with-
rawal (one in each group; P  .316).
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August 2012436 Renaud et alThe 89 elderly patients who had an AVF were com-
pared with 20 elderly patients who were dialyzed solely by
TCs but were excluded from the study cohort. Other than
age (mean age, 72 vs 75 years; P  .013), TC exposure
(median, 261 vs 73 days; P  .011), and mortality (12.8%
vs 90%; P .001), there was no significant difference in sex
(60% vs 46% female), diabetes mellitus (70% vs 75%), CAD
(50% vs 65%), PAD (22.5% vs 30.0%), late referrals (22.5%
vs 25%), and catheter-related infections (0.68 vs 1.87/
1000 catheter-days) between the AVF and TC-only co-
horts, respectively. All-cause infections accounted for four
of 10 deaths (40%) in the AVF group vs six of 18 deaths
(33%) in the TC group (P .001). More patients dialyzing
exclusively by TC withdrew from dialysis (five vs one).
DISCUSSION
Our results are, to our knowledge, the first to show that
primary AVFs have comparable rates of maturation, salvage
interventions, complications, and survival in an elderly vs
nonelderly multiethnic Asian ESRD population. They sup-
port published guideline recommendations on AVFs as the
primary vascular access across all ages. They also highlight
the more important and significant role of nonage clinical
factors on AVF outcomes in this population.
A small number of observational studies have provided
increasingly supportive evidence for an AVF-first approach
in the elderly.19-25 Positive findings have also been de-
scribed in multiethnic cohorts with a very small number of
Asian patients15,26 and in a population with a 60% diabetic
Table II. Primary patency of arteriovenous fistulas (AVFs)
Variablea
6 months, % 12 mont
65 years 65 years 65 years
Overall, % 62.9  3.5 62.9  5.1 41.3  3.6 3
AVF type, %
Radiocephalic 61.8  4.7 59.3  6.7 40.2  4.7 3
Brachiocephalic 69.2  5.7 74.1  8.4 45.4  6.8 4
BBT 53.8  13.8 50.0  17.7 30.8  12.8 1
BBT, Brachiobasilic transposed; NA, not applicable; %, denotes remaining p
aData are shown as the mean  standard error.
bP value by log-rank analysis.
Table III. Secondary arteriovenous fistula (AVF) patency
Variablea
6 months 12 mont
65 years 65 years 65 years 
Overall, % 71.0  3.3 73.0  4.7 57.7  3.6 56
AVF type %
Radiocephalic 70.2  4.4 72.1  6.1 58.6  4.7 55
Brachiocephalic 74.2  5.3 77.7  7.5 55.5  6.2 70
BBT 53.8  13.8 50.0  17.7 44.9  14.1 25
BBT, Brachiobasilic transposed; %, denotes remaining patent AVF by Kapla
aData are shown as the mean  standard error.
bP value by log-rank analysis.ESRD prevalence.27 In a Chinese-only cohort solely con- 5isting of RCAVFs, old age did not influence outcomes, but
combination of diabetes mellitus and old age did.28 These
esults have, however, fueled rather than resolved the con-
roversies regarding age and AVF suitability due to nonuni-
orm definitions for “elderly” and outcome measures and
iased vascular access selection. Our use of tighter defini-
ions and selection criteria, to counter these shortcomings,
esulted in apparently lower patency and maturation rates
omparatively.More so, our use of themore conventionally
ccepted elderly definition of 65 years, as was the case in
ost publications,15,19-22,26,27 while others used 70
ears9,23,24 or even 60 years,25 makes direct comparison
hallenging.
Even in the series with an age cutoff of 65 years, we
id find other methodologic differences. For instance, Lok
t al’s15 use of a nonmaturation rate cutoff of 6 months and
more aggressive vascular access surveillance and interven-
ion strategy, including the use of vascular access coordina-
ors and mandatory access flow monitoring, would explain
heir overall nonmaturation rate of 11% and 1-year PP and
P of 65.1% vs 64.8% and 79.7% vs 75.1%, in the elderly vs
he nonelderly, respectively. It is not surprising therefore
hat the intervention rate in their cohort was 0.81% and
atency rates were higher. Indeed, from our own data, we
howed that AVFs which had endovascular and/or surgical
nterventions had longer survival. Similarly, higher patency
ates from Swindlehurst et al26 (PP and SP at 1 year of 63%
s 54% and 65 % vs 61% among elderly and nonelderly,
espectively) and Jennings et al27 (PP and SP in elderly at
24 months, % Median, %
Pbyears 65 years 65 years 65 years 65 years
5.1 28.7  3.6 24.4  4.8 8.0 7.0 .547
6.6 28.1  4.5 19.0  6.1 9.0 7.0 .582
9.7 31.1  6.7 33.3  9.7 8.0 11.0 .710
11.7 NA NA 6.0 5.0 .392
AVF by Kaplan-Meier and log-rank analysis.
24 months Median
Pbears 65 years 65 years 65 years 65 years
5.3 47.1  3.9 47.4  5.5 20.0 16.0 .990
6.8 47.0  5.1 46.8  7.0 20.0 16.0 .820
8.8 48.5  6.7 55.5  10.5 21.0 26.0 .370
15.3 44.9  14.1 25.0  15.3 9.0 5.0 .513
er and log-rank analysis.hs, %
65
6.7 
6.9 
7.5 
5.4 
atenths
65 y
.8 
.0 
.2 
.0 
n-Mei9.9% and 96.6% at 2 years, respectively) were based on
4
B
p
t
n
6
s
o
a
a
n
k
l
m
e
e
T
a
a
V
F
N
D
C
P
E
H
D
A
C
c
a
T
a
V
A
F
N
D
C
P
E
A
O
N
H
D
C
c
a
b
m
c
JOURNAL OF VASCULAR SURGERY
Volume 56, Number 2 Renaud et al 437heterogeneous cohorts consisting of either both AVFs and
grafts, both primary and secondary AVFs, or both upper
limb and lower limb accesses, making comparisons difficult.
Furthermore, only two of the studies mentioned whether
both nonmature vascular accesses and primary failure cases
were included in patency and maturation rate analysis.15,26
Excluding failed cases, especially technical failures and early
thromboses, has been shown to inflate outcome mea-
sures.15-17
The nonmaturation rate of our primary BBTAVF ap-
Fig 2. Kaplan-Meier patient survival curves for (A) primary pa-
tency and (B) secondary patency for patients aged 65 (group A)
and65 years (group B). Number at risk is indicated below graph.
The dotted lines indicate when standard errors are 10% of the
mean estimate and the curve becomes imprecise.pears excessive compared with published rates of 5% to d0%.29 However, our cohort consisted of only primary
BTAVFs, whereas published rates are based on both
rimary and secondary BBTAVFs, a much longer matura-
ion cutoff of up to 1 year, and narrower definition of
onmaturation (ie, primary failure rate only).
Overall, nonmaturation has been reported as high as
7%, even under a randomized controlled setting,30 and
hould not be looked at as a failure but rather as an
pportunity to intervene and salvage the vascular accesses,
s was elegantly demonstrated by Turmel-Rodrigues et
l,31 who showed lesions in those instances were predomi-
antly inflow stenoses as in our cohort.
The effect of female sex on AVF maturation is well
nown.11,15 The advantage enjoyed by men was, however,
ost at 6 months, suggesting probably underlining hor-
onal, vessel reactivity, and platelet aggregation differ-
nces in women in the early postoperative period. The
ffect of starting dialysis with a TC on maturation may be
able IV. Effect of independent variables on
rteriovenous fistula (AVF) survival in patients aged 65
nd 65 years
ariable HR (95% CI) P
emale sex 0.864 (0.613-1.220) .407
on-Chinese 0.622 (0.439-0.881) .008
iabetes mellitus 1.404 (0.915-2.155) .121
oronary artery disease 1.502 (0.912-2.472) .110
eripheral artery disease 0.757 (0.498-1.151) .193
arly referrala 1.289 (0.857-1.940) .223
D initiation with TC 0.549 (0.297-0.841) .009
istal radiocephalic AVF 0.688 (0.367-1.288) .242
VF salvage interventions 2.503 (1.695-3.6970) .000
I, Confidence interval;HD, hemodialysis;HR, hazard ratio; TC, tunneled
atheter.
First nephrology 6 months before HD initiation.
able V. Effect of independent variables on
rteriovenous fistula (AVF) nonmaturation
ariable HR (95% CI) P
ge 65 1.127 (0.790-1.608) .405
emale sex 1.568 (1.148-2.143) .003
on-Chinese 1.241 (0.965-1.596) .090
iabetes mellitus 1.054 (0.900-1.235) .511
oronary artery disease 1.089 (0.829-1.431) .544
eripheral artery disease 1.095 (0.669-1.792) .760
arly referrala 1.394 (0.919-2.115) .132
ntiplatelets 1.039 (0.806-1.339) .808
ptimal vesselsb 0.851 (0.608-1.189) .410
onmaturation score 3c 1.094 (0.918-1.303) .309
D initiation with TC 1.623 (1.400-1.881) .004
istal radiocephalic AVF 0.933 (0.768-.133) .537
I, Confidence interval;HD, hemodialysis;HR, hazard ratio; TC, tunneled
atheter.
First nephrology 6 months before HD initiation.
Veins  2.5 mm and/or arteries 2.0 mm based on sonographic venous
apping.
Predictive maturation score based on Lok et al.16ue to the multiple hospitalizations and venipunctures
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August 2012438 Renaud et alassociated with TC leading to poorer-quality vessels, and
this agrees with the findings of Ramani et al.32 The associ-
ation between increased AVF survival and Chinese race
(compared with non-Chinese) has not been reported be-
fore due to the small number of Chinese patients in previ-
ous multiethnic cohorts and could be a reflection of genetic
differences or better preoperative vein preservation. A re-
cent publication on ethnicity and vascular access outcomes
attributed ethnic differences in vascular access outcomes to
timeliness of predialysis nephrology care,33 although our
own data showed Chinese and non-Chinese patients had
equivalent timely referral and vessel adequacy.
Our findings seem to agree more with those from
Weale et al.34 In their large, multiethnic cohort in which
15% of patients but no nonwhites were aged80 years and
92% received a primary RCAVF or BCAVF, 2-year SP in
those two accesses was 27.1% vs 36% and 33.6% vs 39.2% in
elderly and nonelderly, respectively. Nonmaturation was
46% in RCAVFs, and female sex and dialysis initiation with
a TC were associated with nonmaturation. This further
reinforces our argument that the differences between our
outcomes and those of other publications are more due to
patient and access selection rather than center-specific tech-
nical issues. We did show comparable demographic and
clinical characteristics between elderly patients who re-
ceived AVFs and those exclusively dialyzed by TC, indicat-
ing our elderly cohort was not overselected and was repre-
sentative of the average patients starting dialysis at our
center.
Our RCAVF rate was high (59%), as was the case in
three other studies15,28,34 due perhaps to adequate preop-
erative vein capital preservation and our center-specific,
distal AVF-first focus. RCAVF patency rates were compa-
rable to those of upper arm AVF despite a recent meta-
analysis conclusion that such accesses have inferior out-
Table VI. Procedures performed to maintain
arteriovenous fistula (AVF) patency and survival
Type of procedure 65 years (No.) 65 years (No.)
Angioplasty
Inflow stenosisa 41 17
Outflow stenosisb 14 11
Combined stenosis 1 2
Stenting 2 2
Mechanical thrombolysis 1 0
Surgical intervention
Anastomotic revision 5 3
Superficialization 2 1
Collateral ligation 6 2
Thrombectomy 1 2
DRIL 1 0
Othersc 6 0
DRIL, Distal revascularization interval ligation.
aArterial, anastomotic, and juxta-anastomotic stenosis.
bIncludes one case of brachiocephalic and superior vena cava stenosis, both
stented.
cFour aneurysm repairs and two fistula infection drainages.comes in the elderly.35 However, a distal AVF-first Cpproach needs to be backed by an aggressive vein capital
reservation preoperatively and surveillance and interven-
ion strategy postoperatively to reduce and address its high
ailure rate. We also showed AVFs in the elderly, despite
aving a higher technical failure rate after PTA, have com-
arable cumulative survival overall after PTA to nonelderly
nd hence should not be denied salvage interventions.
nterestingly, lack of association between age and nonma-
uration from our cohort indicates that preoperative non-
aturation scoring16 does not have much application in
ur population, implying routine clinical examination and
onitoring should remain the standard of care.
Several limitations, however, deserve mention. This
as a retrospective single-center study in Asia and may
herefore lack external generalizability. Other outcome risk
actors, such as body mass index, smoking history, and
ctual vessel size, as well as experience of the surgeons,
ursing skills, and techniques in AVF cannulation, dialysis
dequacy, and intradialytic hypotension, were not ana-
yzed. The standard mean error was 10% of the mean
stimate in a number of instances because of sample size
ffect and may have confounded the accuracy of our AVF
atency rates. Maturation could have been defined by a
ore objective criteria such as the Kidney Foundation
isease Outcomes Quality Initiative rule of 6.12 The use of
C removal as a criterion for maturation meant that delays
n TC removal and scheduling of the second stage of
BTAVFs negatively affected maturation rates in especially
BTAVFs. Analysis of early elderly (aged 65-80 years) and
ate elderly (aged 80 years) could have further identified
he subgroup most at risk but could not be done due to
mall sample size. None of these limitations, however,
nvalidate our findings that AVF survival is similar in elderly
nd younger incident hemodialysis patients.
ONCLUSIONS
Elderly patients from an aging, multiethnic ESRD pop-
lation with a high diabetes mellitus burden have equiva-
ent AVF outcomes, procedures, and complications as the
onelderly, regardless of the type of AVF used, although
verall nonmaturation remains high. Prior dialysis with a
C, non-Chinese race, and absence of endovascular or
urgical interventions are important risk factors for AVF
oss, whereas female sex and prior dialysis by catheter
ignificantly affect maturation. Although patient selection
s still important, elderly Asian patients suitable for surgery
hould not be denied any type of AVF solely because of age.
We thank Valerie Ma for organizing and setting up the
ascular access database and providing valuable data for the
rite up of the manuscript.
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